Detalhe da pesquisa
1.
A Mechanism Underpinning the Bioenergetic Metabolism-Regulating Function of Gold Nanocatalysts.
Small
; 20(8): e2304082, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37767608
2.
Multicenter expanded access program for access to investigational products for amyotrophic lateral sclerosis.
Muscle Nerve
; 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38842106
3.
Evidence of brain target engagement in Parkinson's disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials.
J Nanobiotechnology
; 21(1): 478, 2023 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38087362
4.
Gold Coast diagnostic criteria: Implications for ALS diagnosis and clinical trial enrollment.
Muscle Nerve
; 64(5): 532-537, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34378224
5.
Correction: Evidence of brain target engagement in Parkinson's disease and multiple sclerosis by the investigational nanomedicine, CNM- Au8, in the REPAIR phase 2 clinical trials.
J Nanobiotechnology
; 22(1): 16, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38167088
6.
Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension.
EClinicalMedicine
; 60: 102036, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37396808
7.
Study protocol of RESCUE-ALS: A Phase 2, randomised, double-blind, placebo-controlled study in early symptomatic amyotrophic lateral sclerosis patients to assess bioenergetic catalysis with CNM-Au8 as a mechanism to slow disease progression.
BMJ Open
; 11(1): e041479, 2021 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33431491
8.
Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis.
Sci Rep
; 10(1): 1936, 2020 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32041968